INTRODUCTION
Use of cocaine has increased dramatically since the 1980s among various segments of the population. Specifically, its use has increased among pregnant women 1 and is particularly prevalent among innercity women. Approximately 17% of inner-city women have taken cocaine at least once during their pregnancy. 2 Due to this increased cocaine use among pregnant women, numerous studies have been done to assess the effect of in utero cocaine exposure on pregnancy outcome, the developing fetus, and neonatal complications.
Cocaine use during pregnancy has been associated with younger gestational age at delivery, lower birth weight, increased incidence of preterm labor and delivery, and small for gestational age infants. 3 These clinical outcomes are consistent with animal data that have demonstrated an increase in maternal blood pressure and a decrease in uterine blood flow due to the vasoconstrictive properties of cocaine. 4, 5 By reducing uterine blood flow, cocaine impairs the transfer of oxygen and nutrients to the fetus. Also, cocaine use by women has been linked to an increased risk of spontaneous abortion and of stillbirth associated with abruptio placenta. 6, 7 Due to the vasoconstrictive properties of cocaine, it has been hypothesized that cocaine-exposed newborns would have an increased risk of intraventricular hemmorhage (IVH) and necrotizing enterocolitis (NEC). As for the incidence of IVH among cocaine-exposed very low birth weight (VLBW) infants, the data have been conflicting to date. 7 Sehgal et al. 8 found an increased incidence of NEC without an increased risk of IVH.
Recent studies have also attempted to assess the effect of intrauterine cocaine exposure on the development of respiratory distress syndrome (RDS) in VLBW infants. However, much controversy still exists in this area. Several studies found that intrauterine cocaine exposure did not alter the incidence of RDS in these VLBW infants. 9, 10 In contradistinction, one retrospective case-control study and one prospective study did demonstrate a
OBJECTIVES:
This study examined the effects of intrauterine cocaine exposure on very low birth weight infants with respect to their surfactant requirement and need for ventilatory support.
STUDY DESIGN:
A retrospective cohort study was conducted on infants with birth weight between 750 and 1500 g admitted to the neonatal intensive care unit between January 1992 and January 1995.
RESULTS:
Of the 149 infants studied, 48 infants were exposed only to cocaine and 101 infants had no drug exposure. There were no significant differences between the two groups for gestational age, sex, abruptio placenta, prolonged rupture of membranes, and antenatal steroid usage. The cocaine -exposed group had a significantly greater birth weight ( 1190 vs. 1109, p < 0.02 ), less prenatal care ( 48% vs. 14%, p < 0.00007 ), older maternal age ( 30 vs. 24, p < 0.00002 ), more black race ( 79% vs. 57%, p < 0.01 ), and more rapid plasma reagin (RPR) positivity ( 25% vs. 2%, p < 0.00006 ). There were no significant differences in median APGAR scores, or incidence of necrotizing enterocolitis, retinopathy of prematurity ( ROP ), intraventricular hemorrhage ( IVH ), and bronchopulmonary dysplasia ( BPD ) between the two groups. Cocaine -exposed infants received surfactant treatment less often ( 73% vs. 48%, p < 0.0035 ), received fewer mean doses of surfactant ( 0.4 vs. 10.0, p < 0.0014 ), and were intubated less frequently ( 44% vs. 65%, p < 0.012 ). There was no significant difference between groups for intubation at 24 and 48 hours and for the development of bronchopulmonary dysplasia.
CONCLUSION:
Perinatal cocaine exposure appears to have some significant short -term effects on the need for surfactant replacement therapy and need for initial intubation in respiratory distress syndrome ( RDS ) but no overall effect on the development of BPD. 
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decreased incidence of RDS among premature infants exposed to cocaine.
11,12
The aim of this study was to evaluate the effect of intrauterine cocaine exposure on the VLBW (750 to 1500 g) infant with respect to their meeting clinical criteria for surfactant treatment and for ventilatory support.
METHODS
A retrospective chart review of all infants with birth weight between 750 and 1500 g, gestational age <34 weeks, who were appropriate for gestational age and in-born at Bronx Lebanon Hospital Center between January 1992 and January 1995, was conducted. Bronx Lebanon is a 725-bed general medical center with 3200 deliveries per year and serves an economically disadvantaged population. Due to the high prevalence of drug use in this population, all infants admitted to the neonatal intensive care unit received urine toxicology testing.
Data were collected from the charts regarding maternal age and race, sex of the infant, birth weight, gestational age, prenatal care history, toxicology results, presence of abruptio placenta, hypertension, and prolonged rupture of membranes ( >24 hours), antenatal steroid use, APGAR scores at 1 and 5 minutes, usage of surfactant, intubation and NCPAP (within the first 6 hours and at 24 and 48 hours after birth), and the development of IVH, NEC, bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP, defined as stage 3 or plus disease), patent ductus arteriosus (PDA), and RPR status.
The medical records of 184 infants were identified of which 160 were available for review and had complete historical and toxicological data available. Eleven infants had mothers who used drugs other than cocaine or drugs in addition to cocaine and were excluded from the analysis. The 149 infants who met the study criteria were divided into two groups (cocaine and non-cocaine group) based on maternal history and/or urine drug screens. Cocaine-exposed infants (n=48) consisted of those with positive urine toxicology for only cocaine or a positive history of only cocaine use. The nonexposed infants (n=101) had a negative urine toxicology and a negative history.
Quantitative urine drug testing was done using gas chromatography and confirmed by mass spectrophotometry. In addition to testing for cocaine and benzoylecgonine (the major urinary metabolite of cocaine), opiates, methadone, barbiturates, phencyclidine, and marijuana were tested. All infants received standard neonatal intensive care. RDS was diagnosed based on clinical signs such as grunting, retractions, need for O 2 , positive airway pressure or mechanical ventilation, and radiologic evidence of RDS within the first 6 hours of life. Treatment with exogenous surfactant (Survanta) was given to those newborns with a diagnosis of RDS and mechanically ventilated with a fraction of inspired O 2 >0.4. Pretreatment was administered if the infant continued to require a fraction of inspired O 2 >0.4 after 6 hours. Data were analyzed using -squared analysis, Student's t-test, and multiple logistic regression analysis. A p value of <0.05 was considered significant. Database V for Windows was used for data entry. EpiInfo Version 6 was used for -squared analysis and Student's t-test and SPSS 8 was used for multiple logistic regression analysis. The study had a power of 0.8 to detect a 50% reduction in the primary outcome variable of surfactant usage.
RESULTS
Of the 149 subjects included in our study, 48 were exposed to only cocaine and 101 were non-cocaine-exposed. Infants in the cocaine group had an older maternal age, greater percentage of blacks, greater birth weight, less prenatal care, more abruptio placenta, and more positive syphilis serology. The groups did not differ with respect to sex, gestational age, maternal hypertension, antenatal steroid use, and prolonged rupture of membranes ( Table 1) .
As for neonatal complications, the two groups did not differ with respect to APGAR scores at 1 and 5 minutes or the incidence of IVH, NEC, ROP, and PDA (Table 2) .
With respect to respiratory complications, the cocaine-exposed group had a significantly lower incidence of surfactant treatment (73% vs. 48%, p=0.0035) as well as a lower mean number of surfactant doses (0.4 vs. 1.0, p=0.0014) and incidence of initial intubation (44% vs. 65%, p=0.012). However, incidence of intubation at 24 and 48 hours and the incidence of BPD was not significantly different between the two groups (Table 3) .
Data were also analyzed by multiple logistic regression analysis to determine the significance of multiple perinatal risk factors on respiratory outcome. Of these risk factors, cocaine exposure ( p=0.0188), gestational age ( p=0.0001), and prolonged rupture of membranes ( p=0.0127) had significant independent effects on surfactant use (Table 4) . Although incidence of initial intubation was lower in the cocaine-exposed group based on -squared analysis, when multiple logistic regression analysis was performed using the initial intubation as the dependent variable, only gestational age ( p=0.0000) and sex ( p=0.0023) had a significant effect (Table 5) .
DISCUSSION
This study demonstrated a significantly decreased usage of surfactant treatment in VLBW infants exposed prenatally to cocaine. The effect of cocaine exposure on surfactant treatment remained significant even when maternal factors or conditions known to accelerate lung maturity such as prolonged rupture of membranes, maternal hypertension, and antenatal steroid use were also taken into account. 14, 15 Numerous possible mechanisms may explain the effects of cocaine on the apparent requirement for surfactant. Cocaine is a known potent vasoconstrictive agent and causes decreased uterine blood flow in the pregnant ewe through increased resistance in the uterine vascular bed. 4 Similarly, another study on the effects of cocaine found a dose-dependent increase in maternal blood pressure and a decrease in uterine blood flow with accompanying fetal hypoxemia, hypertension, and tachycardia. 5 Thus cocaine appears to affect the fetus in two fashions: by an indirect effect through decreased uterine blood flow with placental insufficiency, and a direct adrenergic effect on the fetus. We speculate that decreased uterine blood flow and subsequent hypoxemia is analogous to stress placed on the fetus during hypertensive disease of pregnancy. In 1980, Yoon et al. 16 demonstrated a decreased incidence of RDS in infants born to hypertensive mothers due to accelerated fetal lung maturity. Gluck and Kulovich 14 also found an association between maternal hypertension and accelerated fetal lung maturity as assessed by amniotic fluid phospholipid analysis.
In addition to the vasoconstrictive properties of cocaine, the drug is also known to block the reuptake of catecholamines at nerve terminals and therefore increase circulating levels of catecholamines in pregnant women. 5 We speculate that cocaine use near the time of delivery may serve to increase surfactant secretion and resorption of lung fluid due to increased catecholamine levels. 17, 18, 19 This may explain the transient improvements noted in the respiratory status of cocaine-exposed newborns and their decreased need for surfactant.
Preliminary animal data have been conflicting so far with respect to the effects of cocaine on fetal lung maturation. Sosenko in 1991 19 demonstrated an increased surfactant maturation in fetal rats following cocaine administration to pregnant rats. The exact mechanism by which cocaine may do this remains unclear. Another study using alveolar type II cells from adult female rabbits suggested that the direct effect of cocaine is to impair surfactant phospholipid synthesis and subsequently reduce its secretion. 20 Further work clearly needs to be done to elucidate the molecular effect of cocaine on surfactant production.
Our study also demonstrated a significantly lower need for initial intubation among the cocaine-exposed babies. This may also be explained by the drug causing a stress on the fetus and by its increasing the resorption of lung fluid due to increased catecholamine levels as previously hypothesized. However, this effect was no longer present at 24 and 48 hours of life nor did it impact the development of bronchopulmonary dysplasia. Although there was a significant reduction in surfactant use between the two groups, failure to find a difference in rates of intubation at 24 and 48 hours as well as the incidence of BPD and other morbidities may be related to the relatively small sample size of this study and the lack of power to prove these effects. This may also be related to factors such as the timing of drug use and the amount of the drug that was used throughout the pregnancy. These factors could not be assessed accurately. Whether the critical factor is chronic stress on the fetus with maturation of the surfactant system or the more transient effect of high catecholamine levels perinatally causing surfactant secretion and lung fluid resorption remains unclear. Similarly, the greater the amount of drug that is used near delivery will create an even greater stress on the fetus and may actually serve to mature the lungs more quickly. When the data were analyzed by multiple regression analysis to determine the effect of independent variables on the need for intubation, only gestational age and sex had a significant impact. This indicates that many factors, in addition to drug use, determine the respiratory status of a VLBW infant and confound the clinical picture. Future studies that separate these various factors and that examine concomitant alcohol and tobacco use, in addition to assessing the timing, duration, and quantity of cocaine used may help understand the effect of cocaine on the respiratory status of VLBW infants.
The infants in our cocaine-exposed group also had mothers with a significantly increased age, less prenatal care, more reactive VDRL, more abruptio placenta, and were predominantly black. These features have all been previously observed in cocaine-exposed infants. 2 One unusual characteristic about the cocaine-exposed babies in our study was that they had a significantly greater birth weight than the nonexposed babies. This is in contrast to previous studies that have reported lower mean birth weights among cocaine babies. 8 This outcome needs to be further clarified by future studies that focus on the timing and amount of drug used. Cocaine-using mothers in our group could have used predominantly the drug close to the time of delivery, which would not have a great impact on birth weight, whereas drug use throughout pregnancy would most likely have a more significant effect. This behavior could be explained by the desire of some mothers to promote delivery through cocaine use.
In summary, our study found a significantly decreased need for surfactant treatment and initial intubation in the cocaine-exposed infants. There remains a need for further molecular studies on the developing surfactant system, as well as the developing lung and its adaptation to extrauterine life. One of the limitations of our study is the lack of information on drug use early on in pregnancy, other than was obtained by history. The use of urine toxicology testing of our infants only can detect drug use for a period of days before delivery. Studies need to be done on the relative effects of timing and dosage of cocaine and other substances on the developing fetus throughout pregnancy.
